Popular Searches

The Tisch Cancer Institute

Home

About

THE TISCH CANCER INSTITUTE

Scholars Program

CONNECT WITH US

About

The Tisch Cancer Institute is an interdisciplinary nexus of cancer investigation and treatment. We aim to advance patient outcomes both within and beyond New York City, and through our collaborative infrastructure, we conduct award-winning research, serve a diverse patient community, and educate future leaders in oncology.

Located within the main campus of the Mount Sinai Health System, The Tisch Cancer Institute was established in 2008 through the generosity of James and Merryl Tisch. It is currently led by Director Ramon Parsons, MD, PhD, and was designated a National Cancer Institute-Designated Cancer Center first in 2015, and again in 2020.

With direct cancer-related funding of over 40 million, The Tisch Cancer Institute has fostered four collaborative cancer research programs to advance basic, clinical, and population health cancer research. The Institute’s cancer research programs are supported by seven shared resources and draws upon the extensive collaborations of over 170 members.

Our catchment area includes New York City, as well as its surrounding areas, and our research programs are focused on the needs of the diverse populations that live within this region. Currently we conduct extensive research in liver, prostate, breast, colorectal and lung cancers, as well as multiple myeloma. The Institute’s Clinical Research Support Unit, which includes an Early Phase Trials Unit, provides the infrastructure to conduct novel, investigator-initiated protocols developed by our researchers and supported by our staff members.

The Mount Sinai Hospital, which is situated on the same main campus as The Tisch Cancer Institute, delivers clinical care for our patients. Inpatient cancer treatment facilities are provided in the Guggenheim Pavilion, while ambulatory cancer services are provided at The Derald H. Ruttenberg Treatment Center. Radiation oncology and cancer imaging reside in the same building as the Center, allowing easy access to both standard treatment and clinical research-related procedures.

Find A Clinical Trial Make a Gift Discover Careers

Meet the Director

Ramon Parsons, MD, PhD

DIRECTOR, THE TISCH CANCER INSTITUTE

PROFESSOR & CHAIR | Oncological Sciences

PROFESSOR | Medicine, Hematology and Medical Oncology

Ramon E. Parsons, MD, PhD, is Director of The Tisch Cancer Institute (TCI) and Dean for...

Read the Message From the Director

Leadership

Ramon Parsons, MD, PhD

Ramon Parsons, MD, PhD

Director

Joseph A. Sparano, MD

Joseph A. Sparano, MD

Deputy Director

SHARON M MIAS

SHARON M MIAS

Associate Director, Administration

Stuart A Aaronson, MD

Stuart A Aaronson, MD

Associate Director, Basic Research

Matthew Galsky, MD

Matthew Galsky, MD

Associate Director, Translational Research

Karyn A Goodman, MD, MS

Karyn A Goodman, MD, MS

Associate Director, Clinical Research

Emanuela Taioli, MD, PhD

Emanuela Taioli, MD, PhD

Associate Director, Population Science

Cardinale Smith, MD, PhD

Cardinale Smith, MD, PhD

Associate Director, Community Outreach and Engagement

Janice L Gabrilove, MD

Janice L Gabrilove, MD

Associate Director, Training and Education

Jerry Chipuk, PhD

Jerry Chipuk, PhD

Associate Director, Shared Resources

Luis M Isola, MD

Luis M Isola, MD

Associate Director, Cancer Clinical Services

Madhu Mazumdar, PhD

Madhu Mazumdar, PhD

Associate Director, Quantitative Data Services

Advancing Care For All

Ramon Parsons, MD, PhD

“Ensuring our clinical trials and advanced therapies are equitable and accessible remains a central goal of The Tisch Cancer Institute.”

Carousel Background Image 2

Ramon Parsons, MD, PhD

“Ensuring our clinical trials and advanced therapies are equitable and accessible remains a central goal of The Tisch Cancer Institute.”

Ramon Parsons, MD, PhD

“Ensuring our clinical trials and advanced therapies are equitable and accessible remains a central goal of The Tisch Cancer Institute.”

Discover the Latest

Researcher using microscope

2025-02-13 00:00:00.0

Mount Sinai-Led Study Suggests Common Cancer Treatment Does Not Work Well for Hospitalized Patients

Treatment resistance

2025-02-12 00:00:00.0

Mount Sinai Researchers Discover Why Some Colon Cancers Resist Treatment

2025-01-23 00:00:00.0

New Mount Sinai Trial Reveals Major Advance in Treatment of Aggressive Lymphoma

Doctor adjusting microscope

2025-01-09 00:00:00.0

Breakthrough Treatment for Liver Cancer Shows Big Promise in Global Study

REsearcher using computer

2025-01-06 00:00:00.0

Mount Sinai Researchers Create AI Tool to Democratize Access to Cancer Immunotherapy

Doctor adjusting microscope

2024-12-18 00:00:00.0

Mount Sinai Study Reveals Immune-Modulatory Mechanism of Lurbinectedin in Small-Cell Lung Cancer

2024-12-16 00:00:00.0

Dubin Breast Center Annual Gala at Ziegfeld Ballroom Raises $3.8 Million

2024-12-11 00:00:00.0

Mount Sinai’s Elvin Wagenblast Honored by Leukemia & Lymphoma Society for Advancing Research in Childhood Leukemia

Contact Us

The Tisch Cancer Institute

One Gustave L. Levy Place

Box 1128

New York, NY 10029-6574

Christine Ponder, PhD, MPA
Director, Research Administration

Email

Patient Information
The Clinical Research Support Unit

212-824-7391

Email